Live Breaking News & Updates on Chinese children cancer group

Stay informed with the latest breaking news from Chinese children cancer group on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Chinese children cancer group and stay connected to the pulse of your community

Better CNS Control in Children With ALL: 'Goldilocks' Approach

Better CNS Control in Children With ALL: 'Goldilocks' Approach
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.

Germany , China , Eppendorf , Nordrhein-westfalen , Hamburg , Shanghai , United-kingdom , Scotland , Chinese , Jingyan-tang , Gabriele-escherich , Christina-halsey

Alphagalileo > Item Display

Price:
Scientists atSt. JudeChildren’s Research Hospital are working with colleagues in China to develop better therapy for childhood acute lymphoblastic leukemia (ALL). Results from a large phase 3 noninferiority clinical trial definitively showed that vincristine and dexamethasone pulses can be eliminated in patients with low-risk disease. The findings were published today in
The
Lancet Oncology.
Adding the chemotherapy vincristine plus a steroid (originally prednisone, and later dexamethasone) as pulse therapy for childhood ALL has been part of standard care since the 1970s. This is despite their being associated with neuropsychological side effects, neuropathy and other late effects. However, to date studies about the need for prolonged treatment with pulse therapy have been inconclusive.

Tongji , Sichuan , China , Huazhong , Hubei , Shanghai , Hong-kong , Nanjing , Jiangsu , Hua-jiang , Guangxi , Guangzhou

International collaboration aims to develop better therapy for childhood acute lymphoblastic leukemia

International collaboration aims to develop better therapy for childhood acute lymphoblastic leukemia
Scientists at St. Jude Children's Research Hospital are working with colleagues in China to develop better therapy for childhood acute lymphoblastic leukemia (ALL). Results from a large phase 3 noninferiority clinical trial definitively showed that vincristine and dexamethasone pulses can be eliminated in patients with low-risk disease. The findings were published today in
The
Lancet Oncology.
Adding the chemotherapy vincristine plus a steroid (originally prednisone, and later dexamethasone) as pulse therapy for childhood ALL has been part of standard care since the 1970s. This is despite their being associated with neuropsychological side effects, neuropathy and other late effects. However, to date studies about the need for prolonged treatment with pulse therapy have been inconclusive.

China , Chinese , Emily-henderson , Jude-children-research-hospital , Chinese-children-cancer-group , Jude-department-of-oncology , Jude-children , Research-hospital , Ching-hon-pui , Jude-department , Chinese-children , Cancer-group

International collaboration helps refine treatment for childhood leukemia

International collaboration helps refine treatment for childhood leukemia
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Tongji , Sichuan , China , Huazhong , Hubei , Shanghai , Hong-kong , Nanjing , Jiangsu , Hua-jiang , Guangxi , Guangzhou